Alumis Inc./$ALMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alumis Inc.
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
Ticker
$ALMS
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
183
ISIN
US0223071020
Website
Alumis Inc. Metrics
BasicAdvanced
$182M
-
-$8.31
-
-
Price and volume
Market cap
$182M
52-week high
$10.49
52-week low
$3.18
Average daily volume
908K
Financial strength
Current ratio
3.731
Quick ratio
3.475
Long term debt to equity
17.429
Total debt to equity
18.941
Management effectiveness
Return on assets (TTM)
-101.07%
Return on equity (TTM)
-247.05%
Valuation
Price to revenue (TTM)
7.96
Price to book
1.08
Price to tangible book (TTM)
1.08
Price to free cash flow (TTM)
-0.473
Growth
Earnings per share change (TTM)
-88.96%
Alumis Inc. News
AllArticlesVideos
Alumis to Present at the Jefferies Global Healthcare Investor Conference
GlobeNewsWire·1 week ago
Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis
GlobeNewsWire·1 week ago
Alumis Completes Merger with ACELYRIN
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Alumis Inc. stock?
Alumis Inc. (ALMS) has a market cap of $182M as of June 06, 2025.
What is the P/E ratio for Alumis Inc. stock?
The price to earnings (P/E) ratio for Alumis Inc. (ALMS) stock is 0 as of June 06, 2025.
Does Alumis Inc. stock pay dividends?
No, Alumis Inc. (ALMS) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Alumis Inc. dividend payment date?
Alumis Inc. (ALMS) stock does not pay dividends to its shareholders.
What is the beta indicator for Alumis Inc.?
Alumis Inc. (ALMS) does not currently have a Beta indicator.